Amity University Haryana organized a two day International Conference on Molecular Medicine “From Bench to Bedside and Beyond”. It’s an initiative to decode the complex biology interplay in regulation of transcriptome to proteins. Amity Institute of Integrative Sciences and Health (AIISH) and Amity Institute of Biotechnology (AIB) brought together scientists and enthusiasts in our country and internationally on a common platform where they can share, discuss, thoughts and future plans the myriad facets of epigenetics and proteomics in cancer biology.
Prof. Peter Lobie, Co-Director Of The Precision Medicine And Healthcare Research Center, Tsinghua-Berkeley Shenzhen Institute (Tbsi), China, Dr. Shaohua Ma, from Tsinghua-Berkeley Shenzhen Institute (Tbsi), China, Dr. Yury Rubstov, Assistant Professor, Biochemistry And Molecular Medicine, Department Of Medicine, Moscow etc were the key spokesperson at the conference. Scientists and scholars from more than five countries had gathered to attend and to share their views on molecular medicine. More than 30 papers were presented on first day of two day conference under various sessions, where the best paper will be awarded at the valedictory function of the Conference.
Prof. Peter Lobie, Scientist, in his keynote address said ‘Targeting Growth Harmone dependent cancer progression by inhibition by various factor’ talked about the role of secreted proteins on cancer initiation and progression and evaluation of various molecules for potential therapeutic application. He also described the potential clinical indications where an inhibitor of TFF3 may be useful.
Dr Rajendra Prasad, Director, Amity Institute of Biotechnology while addressing the gathering said, “It is a great platform for the students and researchers to learn from eminent scientists who came together to share their research and findings on the molecular medicine. And it is also a great chance to collaborate with different countries to achieve common goal together”.